Kota Sugiura
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
ASO Visual Abstract: Mastering Robotic SMA Dissection: How the Correct Anatomical Concept Refines Technical Steps in the Left Posterior Approach.
Journal: Annals of surgical oncology
Published: September 03, 2026
Mastering Robotic SMA Dissection: How the Correct Anatomical Concept Refines Technical Steps in the Left Posterior Approach.
Journal: Annals of surgical oncology
Published: March 16, 2026
Incisional hernia after inverted L-shaped incision in open hepatectomy: A topographical analysis and comparison of 2 fascial closure methods.
Journal: Surgery
Published: December 21, 2025
ASO Author Reflections: Technical Challenges and Solutions in Pancreaticoduodenectomy After Perihilar Cholangiocarcinoma Surgery.
Journal: Annals of surgical oncology
Published: October 08, 2025
A Widely Applicable CAD-Based Intraoperative 3D Navigation Method for Hepatopancreatobiliary Surgery.
Journal: Annals of surgical oncology
Published: October 01, 2025
Differences in Right Hepatic Duct Length Among Left-Sided Hepatectomies: Conventional Hepatectomy Versus Extended Hepatectomy Versus Trisectionectomy.
Journal: Journal of hepato-biliary-pancreatic sciences
Published: September 28, 2025
Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis.
Journal: British journal of cancer
Published: August 07, 2025
Surgical Technique and Feasibility of Pancreaticoduodenectomy after Surgery for Perihilar Cholangiocarcinoma.
Journal: Annals of surgical oncology
Published: August 06, 2025
Impact of the stapler method on postoperative pancreatic fistula in robot-assisted pancreaticoduodenectomy: a retrospective study.
Journal: Surgical endoscopy
Published: June 30, 2025
ASO Author Reflections: Optimizing Treatment for Resectable Pancreatic Cancer: CA19-9 > 500 U/mL as a Biologic Indicator for Neoadjuvant Therapy.
Journal: Annals of surgical oncology
Published: April 24, 2025
Resectable Pancreatic Cancer with CA19-9 > 500 U/mL: A Biological Indicator for Survival Benefit with Intensive Neoadjuvant Chemotherapy.
Journal: Annals of surgical oncology
Published: February 14, 2025
Last Updated: 09/26/2026